Fentanyl 0.4 MG Oral Lozenge — RxCUI 310297
RxNorm drug concept · Semantic clinical drug
RxCUI 310297
Semantic clinical drug · SCD
● Current RxNorm concept 2 FDA products
2 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI310297
Official nameFentanyl 0.4 MG Oral Lozenge
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asfentanyl (as fentanyl citrate) 400 MCG Oral Lozenge; fentaNYL citrate 400 MCG Oral Lozenge
FDA products mapped2
Package NDCs mapped2
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Fentanyl Transdermal Patch: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- It treats severe, ongoing pain that needs an opioid and has not been controlled well by other options. It is only for people who are already opioid-tolerant. It is not meant for as...
- Wear each patch continuously for up to 72 hours and follow your prescriber's and the Medication Guide's directions. Avoid heat on or near the patch, such as heating pads, hot tubs...
- Even a used patch still has a lot of fentanyl, and exposure can kill a child. Store patches safely and dispose of them exactly as directed, not in the regular trash. Ask us about h...
- Nausea, vomiting, sleepiness, dizziness, constipation, headache and trouble sleeping are common. Call 911 for slow or shallow breathing or if someone can't be woken up. Call your d...
🕸️ Concept Web — How Fentanyl 0.4 MG Oral Lozenge Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Fentanyl 0.4 MG Oral Lozenge
RxCUI 310297 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 1
The active substance itself — no strength, form, or brand attached yet.
-
Fentanyl
4337IN
-
Fentanyl
-
Brand names 1
The same medicine's trade names. A brand name alone says nothing about strength or form.
-
Actiq
215008BN
-
Actiq
-
Dose forms 9
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Fentanyl Oral Lozenge
372161SCDF -
Fentanyl Lozenge Product
1294774SCDG -
Fentanyl Oral Product
1159058SCDG -
Fentanyl Oral Lozenge [Actiq]
367214SBDF -
Actiq Lozenge Product
1295970SBDG -
Actiq Oral Product
1169909SBDG -
Oral Lozenge
316992DF -
Lozenge Product
1294702DFG - +1 more in this family
-
Fentanyl Oral Lozenge
-
Clinical & branded drugs 3
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Fentanyl 0.4 MG
328388SCDC -
Fentanyl 0.4 MG Oral Lozenge [Actiq]
262219SBD -
Fentanyl 0.4 MG [Actiq]
574688SBDC
-
Fentanyl 0.4 MG
Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Fentanyl 0.4 MG
SCDC · 328388 -
Fentanyl Oral Lozenge
SCDF · 372161 -
Fentanyl Lozenge Product
SCDG · 1294774 -
Fentanyl Oral Product
SCDG · 1159058
Brand-Name Concepts
-
Fentanyl 0.4 MG Oral Lozenge [Actiq]
SBD · 262219 -
Fentanyl 0.4 MG [Actiq]
SBDC · 574688 -
Fentanyl Oral Lozenge [Actiq]
SBDF · 367214 -
Actiq Lozenge Product
SBDG · 1295970 -
Actiq Oral Product
SBDG · 1169909 -
Actiq
BN · 215008
📦 FDA Products & Package NDCs
2 products · 2 package NDCs
2 package NDCs map to RxCUI 310297 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 00093-7866-65 | 30 BLISTER PACK in 1 CARTON (0093-7866-65) / 1 LOZENGE in 1... | Fentanyl Citrate | Teva Pharmaceuticals USA, Inc. | 2015-12-08 |
| 00093-7868-65 | 30 BLISTER PACK in 1 CARTON (0093-7868-65) / 1 LOZENGE in 1... | Fentanyl Citrate | Teva Pharmaceuticals USA, Inc. | 2015-12-08 |
Observed labelers:
Teva Pharmaceuticals USA, Inc. (2)
— this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.